Imaging

PET + FDG underutilized for diagnosis and treatment female reproductive organ cancer, study says

Published in Drug Week, December 2nd, 2005

The use of positron emission tomography (PET) with the radiotracer fluorodeoxyglucose (FDG) is underutilized in diagnosing and treating cancer of the reproductive organs - the cervix, uterus, ovaries, fallopian tubes, vagina and vulva - according to an article in the Journal of Nuclear Medicine.

Doctors are beginning to see the potential of using PET to look inside a woman's body to find gynecologic disease and its progression - and to follow how a treatment works.

PET imaging with FDG is having a great impact on determining the extent of spread of cancers of the reproductive system, especially when doctors get ambiguous results from other...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2005-12-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry